Authors: Chan, JH Hong, JS Hunter, RN Orr, GF Cowan, JR Sherman, DB Sparks, SM Reitter, BE Andrews, CW Hazen, RJ St Clair, M Boone, LR Ferris, RG Creech, KL Roberts, GB Short, SA Weaver, K Ott, RJ Ren, JS Hopkins, A Stuart, DI Stammers, DK

Citation: Jh. Chan et al., 2-amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1, J MED CHEM, 44(12), 2001, pp. 1866-1882

Authors: Darville, T Andrews, CW Sikes, JD Fraley, PL Rank, RG

Citation: T. Darville et al., Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection, INFEC IMMUN, 69(6), 2001, pp. 3556-3561

Authors: Darville, T Andrews, CW Sikes, JD Fraley, PL Braswell, L Rank, RG

Citation: T. Darville et al., Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response, INFEC IMMUN, 69(12), 2001, pp. 7419-7424

Authors: Painter, GR Andrews, CW Furman, PA

Citation: Gr. Painter et al., Conformation and local environment of nucleotides bound to HIV type 1 reverse transcriptase (HIV-1 RT) in the ground state, NUCLEOS NUC, 19(1-2), 2000, pp. 13-29

Authors: Andrews, CW Bennett, L Yu, LX

Citation: Cw. Andrews et al., Predicting human oral bioavailability of a compound: Development of a novel quantitative structure-bioavailability relationship, PHARM RES, 17(6), 2000, pp. 639-644

Authors: Darville, T Andrews, CW Rank, RG

Citation: T. Darville et al., Does inhibition of tumor necrosis factor alpha affect chlamydial genital tract infection in mice and guinea pigs?, INFEC IMMUN, 68(9), 2000, pp. 5299-5305